Wockhardt recalls Indian drugs |
Wockhardt Ltd said it would recall some drugs manufactured at its two plants in India before the US Food and Drug Administration (FDA) banned those sites due to quality concerns. The FDA banned US exports from Wockhardt`s Waluj and Chikalthana plants in central India in 2013, citing manufacturing quality lapses. The agency conducted an inspection of both plants earlier this year. Wockhardt said that several batches of products produced at the plants before the bans were imposed are perhaps still selling in the United States. In February, Wockhardt said the FDA raised fresh concerns regarding the manufacturing quality at the Waluj site.
|
|
|
|